€
0.00
Dec 31
Business Description
Orchid Pharma Ltd
NAICS : 325412
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.86 | |||||
Interest Coverage | 1.4 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 9.22 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 22.5 | |||||
3-Year FCF Growth Rate | 31 | |||||
3-Year Book Growth Rate | 13 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 66.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 41.95 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.04 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 162.2 | |||||
Days Sales Outstanding | 82.67 | |||||
Days Payable | 142.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.5 | |||||
Shareholder Yield % | 3.05 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.06 | |||||
Operating Margin % | 2.28 | |||||
Net Margin % | 12.73 | |||||
ROE % | 11.34 | |||||
ROA % | 7.87 | |||||
ROIC % | 1.75 | |||||
3-Year ROIIC % | 59.94 | |||||
ROC (Joel Greenblatt) % | 12.69 | |||||
ROCE % | 10.9 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 54.56 | |||||
PE Ratio without NRI | 54.85 | |||||
Price-to-Owner-Earnings | 72.49 | |||||
PEG Ratio | 2.64 | |||||
PS Ratio | 6.96 | |||||
PB Ratio | 5.44 | |||||
Price-to-Free-Cash-Flow | 99.25 | |||||
Price-to-Operating-Cash-Flow | 48.19 | |||||
EV-to-EBIT | 52.58 | |||||
EV-to-EBITDA | 41.24 | |||||
EV-to-Revenue | 7.38 | |||||
EV-to-FCF | 106.22 | |||||
Earnings Yield (Greenblatt) % | 1.9 | |||||
FCF Yield % | 0.96 | |||||
Forward Rate of Return (Yacktman) % | 20.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Orchid Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 0 - 0 | ||
Shares Outstanding (Mil) | 40.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Orchid Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Orchid Pharma Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Orchid Pharma Ltd Frequently Asked Questions
What is Orchid Pharma Ltd(FRA:O6PA)'s stock price today?
When is next earnings date of Orchid Pharma Ltd(FRA:O6PA)?
Does Orchid Pharma Ltd(FRA:O6PA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |